Medical Device Network on MSN
Podcast: Which pharma and medtech companies came out on top in 2025 revenues?
The healthcare editorial teams discusses the key trends and growth drivers in companies' recent 2025 financial results.
AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Biotech firms use AI in trials to target patients more ...
In this article, we will look at the 10 Best Performing Pharma Stocks in 2025. On January 8, Michael Yee, global head of biotech research at UBS, appeared on CNBC’s ‘Squawk on the Street’ to discuss ...
Looking back on 2025, a lot happened in the world of healthcare. This year was largely defined by the arrival of the second Trump administration, armed with tariff threats, unorthodox views about ...
Despite continued uncertainty and mounting regulatory challenges, pharma TV ad spend topped $7 billion through the first 11 months of 2025. Recently released data by iSpot.tv found that the ...
It’s been another whirlwind year in the world of pharma marketing. The year’s most enduring narratives revolved around industrywide shifts heavily influenced by Trump administration directives: a ...
Hosted on MSN
Indian Pharmaceutical Industry Transformed By GST Reforms And Research Development In 2025
New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while ...
The pharmaceutical sector is entering 2026 at a critical juncture. While recent initial public offering (IPO) performance has been stellar, with pharma firms claiming five of the top 10 IPO returns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results